Anat's mailing address filed with the SEC is C/O GAMIDA CELL LTD., 116 HUNTINGTON AVENUE, BOSTON, MA, 02116.
Over the last 3 years, insiders at Gamida Cell Ltd have traded over 0$ worth of Gamida Cell Ltd stock and bought 85,483 units worth 132,499$ . The most active insiders traders include Stephen T Wills、Robert I Blum、Jeremy Blank. On average, Gamida Cell Ltd executives and independent directors trade stock every 0 days with the average trade being worth of 699$. The most recent stock trade was executed by Stephen T Wills on 30 September 2022, trading 9,677 units of GMDA stock currently worth 14,999$.
gamida cell is a leader in cellular and immune therapeutics, committed to changing the treatment paradigm for patients with cancer and rare genetic diseases. we are building a broad pipeline based on our proprietary nam technology platform. our lead program, nicord, is in phase 3 development for allogeneic bone marrow transplantation and was granted breakthrough therapy designation by the fda.
Gamida Cell Ltd executives and other stock owners filed with the SEC include: